Cargando…
How Can We “Get the Lead Out” Without Chelators?
Autores principales: | Mazer-Amirshahi, Maryann, Fox, Erin R., Routsolias, Joanne C., Johnson-Arbor, Kelly, Mycyk, Mark B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143065/ https://www.ncbi.nlm.nih.gov/pubmed/34031804 http://dx.doi.org/10.1007/s13181-021-00848-1 |
Ejemplares similares
-
The Coronavirus Disease Pandemic Continues to Challenge Patients in Need of Buprenorphine for Opioid Use Disorder
por: Routsolias, Joanne C., et al.
Publicado: (2021) -
Best Pharmaceuticals for Children: How Far Have We Come?
por: Mazer-Amirshahi, Maryann, et al.
Publicado: (2014) -
The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic
por: Fox, Erin R., et al.
Publicado: (2020) -
Perspective on lead toxicity, a comparison between the United States and Iran
por: Pourmand, Ali, et al.
Publicado: (2012) -
An international perspective of out-of-hospital cardiac arrest and cardiopulmonary resuscitation during the COVID-19 pandemic
por: Ong, Justin, et al.
Publicado: (2021)